• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.系统性红斑狼疮诊断后 10 或 20 年内发生肾衰竭的风险。
J Rheumatol. 2021 Feb;48(2):222-227. doi: 10.3899/jrheum.191094. Epub 2020 Apr 15.
2
Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.在美国肾脏数据系统中,系统性红斑狼疮诊断作为肾衰竭主要病因的验证。
Arthritis Care Res (Hoboken). 2017 Apr;69(4):599-604. doi: 10.1002/acr.22972.
3
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.三个种族群体中的系统性红斑狼疮。十二。诊断后狼疮性肾炎的危险因素。
Lupus. 2002;11(3):152-60. doi: 10.1191/0961203302lu158oa.
4
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.印度北部和中部儿童期起病系统性红斑狼疮患者狼疮性肾炎的预后:25年单中心经验
Lupus. 2016 Apr;25(5):547-57. doi: 10.1177/0961203315619031. Epub 2015 Dec 3.
5
Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.南非儿童系统性红斑狼疮患者的严重疾病表现及不良预后。
Lupus. 2017 Feb;26(2):186-194. doi: 10.1177/0961203316660625. Epub 2016 Aug 19.
6
Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.系统性红斑狼疮的分类:国际系统性红斑狼疮协作诊所标准与美国风湿病学会标准。对来自现实生活中的国际系统性红斑狼疮队列的2055例患者的比较研究。
Arthritis Care Res (Hoboken). 2015 Aug;67(8):1180-5. doi: 10.1002/acr.22539.
7
Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.系统性红斑狼疮患者终末期肾病的风险:一项基于全国人口的研究。
Int J Rheum Dis. 2016 Nov;19(11):1175-1182. doi: 10.1111/1756-185X.12828. Epub 2016 Feb 10.
8
Comparing the 1997 update of the 1982 American College of Rheumatology (ACR-97) and the 2012 Systemic Lupus International Collaborating Clinics (SLICC-12) criteria for systemic lupus erythematosus (SLE) classification: which enables earlier classification of SLE in an urban Asian population?比较1982年美国风湿病学会(ACR - 97)的1997年更新版与2012年系统性红斑狼疮国际协作临床中心(SLICC - 12)的系统性红斑狼疮(SLE)分类标准:哪一项能使亚洲城市人群中SLE的分类更早实现?
Lupus. 2019 Jan;28(1):11-18. doi: 10.1177/0961203318811599. Epub 2018 Nov 21.
9
Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.在一个由338例系统性红斑狼疮患者组成的单中心队列中,死亡、终末期肾病和血栓栓塞事件风险因素的定义。
Ann Rheum Dis. 2002 Dec;61(12):1065-70. doi: 10.1136/ard.61.12.1065.
10
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.系统性红斑狼疮、狼疮性肾炎和终末期肾病:疾病严重程度和进展的实用综述映射。
Lupus. 2020 Aug;29(9):1011-1020. doi: 10.1177/0961203320932219. Epub 2020 Jun 22.

引用本文的文献

1
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis.血液免疫表型分析可识别狼疮性肾炎患者不同的肾脏组织病理学特征及预后情况。
J Clin Invest. 2025 Jun 19. doi: 10.1172/JCI181034.
2
Advances in precision medicine for lupus nephritis: biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies.狼疮性肾炎精准医学的进展:生物标志物和人工智能驱动的诊断、治疗反应预测及靶向治疗
EBioMedicine. 2025 Jun 3;117:105785. doi: 10.1016/j.ebiom.2025.105785.
3
Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System).基于临床和实验室数据预测狼疮性肾炎增殖性组织学类型工具的验证队列:LUCAS研究(狼疮性肾炎分类评估系统)
Lupus Sci Med. 2025 Apr 28;12(1):e001538. doi: 10.1136/lupus-2025-001538.
4
Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes.狼疮性肾炎肾脏缓解后停用免疫抑制剂:复发的预测因素、停药时间及长期结局
Rheumatology (Oxford). 2025 Apr 1;64(4):1894-1903. doi: 10.1093/rheumatology/keae381.
5
Hydroxychloroquine Improves Low Complement Levels.羟氯喹可提高低补体水平。
Arthritis Care Res (Hoboken). 2024 Oct;76(10):1396-1399. doi: 10.1002/acr.25381. Epub 2024 Jul 2.
6
Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.尿活化白细胞细胞黏附分子在系统性红斑狼疮和狼疮性肾炎中的临床血清学关联。
Clin Rheumatol. 2024 Mar;43(3):1015-1021. doi: 10.1007/s10067-024-06883-x. Epub 2024 Jan 31.
7
Immune and molecular landscape behind non-response to Mycophenolate Mofetil and Azathioprine in lupus nephritis therapy.狼疮性肾炎治疗中对霉酚酸酯和硫唑嘌呤无反应背后的免疫和分子格局。
Res Sq. 2024 Jan 12:rs.3.rs-3783877. doi: 10.21203/rs.3.rs-3783877/v1.
8
Lupus Nephritis Biomarkers: A Critical Review.狼疮性肾炎生物标志物:批判性综述。
Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805.
9
East-Asian lupus nephritis in the Hopkins Lupus Cohort.霍普金斯狼疮队列中的东亚狼疮性肾炎
Rheumatol Immunol Res. 2023 Sep 27;4(3):157-161. doi: 10.2478/rir-2023-0022. eCollection 2023 Sep.
10
Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?狼疮性肾炎患者在现实环境中实现疾病缓解:不可能完成的任务?
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003158.

系统性红斑狼疮诊断后 10 或 20 年内发生肾衰竭的风险。

Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.

机构信息

M. Petri, MD, MPH, Division of Rheumatology, Johns Hopkins University School of Medicine;

E. Barr, MPH, L.S. Magder, MPH, PhD, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

出版信息

J Rheumatol. 2021 Feb;48(2):222-227. doi: 10.3899/jrheum.191094. Epub 2020 Apr 15.

DOI:10.3899/jrheum.191094
PMID:32295853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7572868/
Abstract

OBJECTIVE

The frequency of endstage renal disease (ESRD) from systemic lupus erythematosus (SLE) in the United States has not improved over the last few decades in large population datasets. Understanding the risk factors for renal failure in SLE could lead to earlier detection of lupus nephritis and potentially more effective treatments in those with markers of poor prognosis.

METHODS

The Hopkins Lupus Cohort, comprising 2528 patients was used. One hundred fifty-one patients experienced renal failure after SLE diagnosis, defined as dialysis or renal transplant. We estimated the risk of renal failure in subgroups defined by demographics, laboratory tests, and the American College of Rheumatology/Systemic Lupus International Collaborating Clinics (ACR/SLICC) classification criteria satisfied within 1 year of SLE diagnosis.

RESULTS

The overall incidence of renal failure within 20 years of SLE diagnosis was 8.4%. The risk was much higher (20.0%) among those who experienced proteinuria within the first year of diagnosis. Demographic predictors included African American ethnicity [rate ratio (RR) 1.82, = 0.0012] and age ≥ 40 years at SLE diagnosis (RR 0.51 vs those with diagnosis at < 30 yrs of age, = 0.019). Among immunologic markers, low C3 was a strong predictor of renal failure (RR 2.00, = 0.0011).

CONCLUSION

Proteinuria within the first year of diagnosis of SLE is one of the most important predictors of ESRD. Our data also confirm African American ethnicity, younger age at SLE diagnosis, and low C3 as strong predictors of renal failure.

摘要

目的

在美国,过去几十年中,系统性红斑狼疮(SLE)导致的终末期肾病(ESRD)的发病率并未改善。了解 SLE 患者发生肾衰竭的风险因素可能有助于更早地发现狼疮性肾炎,并为那些有预后不良标志物的患者提供更有效的治疗。

方法

使用了包括 2528 例患者的霍普金斯狼疮队列。151 例患者在 SLE 诊断后出现肾衰竭,定义为透析或肾移植。我们根据人口统计学、实验室检查以及在 SLE 诊断后 1 年内满足的美国风湿病学会/系统性红斑狼疮国际合作诊所(ACR/SLICC)分类标准,在亚组中估计肾衰竭的风险。

结果

在 SLE 诊断后 20 年内,肾衰竭的总体发生率为 8.4%。在诊断后第一年出现蛋白尿的患者中,风险更高(20.0%)。人口统计学预测因素包括非裔美国人种族(RR 1.82, = 0.0012)和 SLE 诊断时年龄≥40 岁(RR 0.51,与诊断年龄<30 岁的患者相比, = 0.019)。在免疫标志物中,C3 水平低是肾衰竭的强烈预测因素(RR 2.00, = 0.0011)。

结论

SLE 诊断后第一年的蛋白尿是 ESRD 的最重要预测因素之一。我们的数据还证实,非裔美国人种族、SLE 诊断时年龄较小和 C3 水平低是肾衰竭的强烈预测因素。